Novel growth hormone receptor mutation in a Chinese patient with Laron syndrome

被引:4
作者
Hui, HNT
Metherell, LA
Ng, KL
Savage, MO
Camacho-Hübner, C
Clark, AJL
机构
[1] United Christian Hosp, Dept Paediat & Adolescent Med, Kowloon, Hong Kong, Peoples R China
[2] St Bartholomews & Royal London Sch Med & Dent, Dept Endocrinol, London, England
关键词
Laron syndrome; growth hormone insensitivity; growth hormone receptor; mutation of growth hormone receptor gene;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Laron syndrome, growth hormone (GH) insensitivity syndrome, caused by a mutation of the GH receptor (GHR) gene, is extremely rare in the Chinese population. We report a Chinese girl diagnosed with Laron syndrome at age 1.9 years with height -4.9 SDS, basal GH 344 mIU/ml, IGF-I <12 ng/ml, IGFBP-3 <0.2 mg/ml, and undetectable GHBP. A novel mutation of the GHR, not previously described, was identified at the donor splice site of intron 6.
引用
收藏
页码:209 / 213
页数:5
相关论文
共 25 条
[1]  
Baumann Gerhard, 2002, Am J Pharmacogenomics, V2, P93, DOI 10.2165/00129785-200202020-00003
[2]   Clinical and endocrine characteristics in atypical and classical growth hormone insensitivity syndrome [J].
Burren, CP ;
Woods, KA ;
Rose, SJ ;
Tauber, M ;
Price, DA ;
Heinrich, U ;
Gilli, G ;
Razzaghy-Azar, M ;
Al-Ashwal, A ;
Crock, PA ;
Rochiccioli, P ;
Yordam, N ;
Ranke, MB ;
Chatelain, PG ;
Preece, MA ;
Rosenfeld, RG ;
Savage, MO .
HORMONE RESEARCH, 2001, 55 (03) :125-130
[3]   The extracellular matrix on atherogenesis and diabetes-associated vascular disease [J].
Camejo, G ;
Olsson, U ;
Hurt-Camejo, E ;
Baharamian, N ;
Bondjers, G .
ATHEROSCLEROSIS SUPPLEMENTS, 2002, 3 (01) :3-9
[4]   Commentary - The essential role of IGF-I: Lessons from the long-term study and treatment of children and adults with Laron syndrome [J].
Laron, Z .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (12) :4397-4404
[5]   PRISMATIC CASES - LARON SYNDROME (PRIMARY GROWTH-HORMONE RESISTANCE) FROM PATIENT TO LABORATORY TO PATIENT [J].
LARON, Z .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (05) :1526-1531
[6]   Clinical use of somatomedin-1 yes or no? [J].
Laron Z. .
Pediatric Drugs, 1999, 1 (3) :155-159
[7]   Somatomedin-1 (recombinant insulin-like growth factor-1) - Clinical pharmacology and potential treatment of endocrine and metabolic disorders [J].
Laron, Z .
BIODRUGS, 1999, 11 (01) :55-70
[8]  
Laron Z, 2001, J Pediatr Endocrinol Metab, V14 Suppl 5, P1243
[9]  
LARON Z, 1966, ISRAEL J MED SCI, V2, P152
[10]   EFFECTS OF INSULIN-LIKE GROWTH-FACTOR ON LINEAR GROWTH, HEAD CIRCUMFERENCE, AND BODY-FAT IN PATIENTS WITH LARON-TYPE DWARFISM [J].
LARON, Z ;
ANIN, S ;
KLIPPERAURBACH, Y ;
KLINGER, B .
LANCET, 1992, 339 (8804) :1258-1261